As reported in previous studies, activation of Wnt/β-catenin signaling or its target gene c-myc in prostate cancer promoted tumor progression, while inactivating Wnt/β-catenin signaling restricted tumor growth [10, 11]. The gene discussed is MYC; the disease is neoplasm.